Glucose Health, Inc. Overview
Pro stress-test →Glucose Health formulates, manufactures and distributes soluble-fiber nutrition products supporting healthy glucose metabolism and broader metabolic wellness. The company's flagship brand GlucoDown® competes with diabetic nutrition products such as Glucerna® (Abbott) and Boost® (Nestlé), while its complementary brand Fiber Up® targets metabolic, gut and digestive health as a flavorful alternative to Metamucil® (Procter and Gamble).
Strategic Profile
Pro stress-test →The company's brands are manufactured in the United States and distributed through major national retailers and leading online marketplaces. The company operates primarily in North America, with distribution through Amazon, diabetic sections of the nation's two largest pharmacy chains and other retail channels; revenues approach $1.1 million in recent fiscal years with gross margins above 40%. Since 2019, a core group of investors has made cumulative direct investments approaching $2 million, enabling the company to establish two trademarked soluble fiber-based nutrition brands with commercial traction and shelf placement in the diabetic sections of the nation's two largest pharmacy retailers.
Competitive Landscape
Pro stress-test →GlucoDown® competes with diabetic nutrition products such as Glucerna® (Abbott) and Boost® (Nestlé). Fiber Up® is positioned as a flavorful alternative to Metamucil® (Procter and Gamble). Glucose Health differentiates through patent-pending soluble-fiber formulations and plant-based botanical extracts, with distribution expanding across Amazon, Walgreens, Walmart, and major pharmacy chains.
Industry Context
Glucose Health, Inc. operates in Dietary supplement beverages and functional nutrition.
Key facts
Founded: 2007 · Headquarters: Bentonville, Arkansas · Revenue: $1.1M · Market cap: $2.3M